Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Renaud

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Pediatrie|September 1, 1979
[Alterations in hemostasis during treatment with sodium dipropylacetate (Depakine) (R)]P Monnet, M David, N Philippe, et al.
Kidney International. Supplement|February 1, 1986
Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremiaA Fournier, P Moriniere, J L Sebert, et al.
Nephrologie|January 1, 1988
[Indirect evaluation of the effect of 1 alpha-hydroxyvitamin D3 on intestinal absorption of aluminum]R Demontis, D Reissi, C Noël, et al.
Bone and Mineral|February 1, 1987
Plasma bone Gla-protein: assessment of its clinical value as an index of bone formation in hemodialyzed patientsJ L Sebert, J C Ruiz, A Fournier, et al.
Clinical Nephrology|September 1, 1986
1 alpha(OH) vitamin D3 increases plasma aluminum in hemodialized patients taking AI(OH)3R Demontis, A Leflon, A Fournier, et al.
Annales De Medecine Interne|January 1, 1990
[Epidemiology of primary glomerulonephritis in Picardie]Z Abdulmassih, R Makdassi, N Bove, et al.
Contributions to Nephrology|January 1, 1988
Calcium carbonate and magnesium hydroxide in the prevention of renal osteodystrophy or the demise of aluminum toxicity in uremia. Analysis of 5 years experienceP Morinière, A Fournier, P F Westeel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Erosive osteoarthropathy associated with beta 2-microglobulin amyloidosis in a uraemic patient treated exclusively by long-term haemofiltration with biocompatible membranesH Renaud, A Fournier, P Moriniere, et al.
Kidney International. Supplement|March 1, 1988
Aluminum load and histological bone disease in hemofiltration and hemodialysisA Fournier, P Moriniere, P Fohrer, et al.
Nephron|January 1, 1989
Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminumP Morinière, M Cohen-Solal, S Belbrik, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Pediatrie|September 1, 1979
[Alterations in hemostasis during treatment with sodium dipropylacetate (Depakine) (R)]P Monnet, M David, N Philippe, et al.
Kidney International. Supplement|February 1, 1986
Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremiaA Fournier, P Moriniere, J L Sebert, et al.
Nephrologie|January 1, 1988
[Indirect evaluation of the effect of 1 alpha-hydroxyvitamin D3 on intestinal absorption of aluminum]R Demontis, D Reissi, C Noël, et al.
Bone and Mineral|February 1, 1987
Plasma bone Gla-protein: assessment of its clinical value as an index of bone formation in hemodialyzed patientsJ L Sebert, J C Ruiz, A Fournier, et al.
Clinical Nephrology|September 1, 1986
1 alpha(OH) vitamin D3 increases plasma aluminum in hemodialized patients taking AI(OH)3R Demontis, A Leflon, A Fournier, et al.
Annales De Medecine Interne|January 1, 1990
[Epidemiology of primary glomerulonephritis in Picardie]Z Abdulmassih, R Makdassi, N Bove, et al.
Contributions to Nephrology|January 1, 1988
Calcium carbonate and magnesium hydroxide in the prevention of renal osteodystrophy or the demise of aluminum toxicity in uremia. Analysis of 5 years experienceP Morinière, A Fournier, P F Westeel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Erosive osteoarthropathy associated with beta 2-microglobulin amyloidosis in a uraemic patient treated exclusively by long-term haemofiltration with biocompatible membranesH Renaud, A Fournier, P Moriniere, et al.
Kidney International. Supplement|March 1, 1988
Aluminum load and histological bone disease in hemofiltration and hemodialysisA Fournier, P Moriniere, P Fohrer, et al.
Nephron|January 1, 1989
Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminumP Morinière, M Cohen-Solal, S Belbrik, et al.
Pageof 7